Phase 4 Psoriasis Trial, Recruiting (NCT06398106)

Phase 4 Psoriasis Trial, Recruiting NCT06398106 Sponsor: University Hospital, Ghent Condition: Psoriasis

Printed from Voxsanity (voxsanity.com.au) — NCT06398106 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Psoriasis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older
You have been formally diagnosed with plaque psoriasis by a qualified skin specialist (dermatologist)
You are currently being treated with one of these three medications — secukinumab, ixekizumab, or guselkumab — and have been taking it at the standard dose for at least 6 months
You are willing and able to sign a consent form before the study begins

Who may not be able to join:

You are taking one of these biologic medications mainly for a condition other than plaque psoriasis (for example, if your primary reason for the medication is rheumatoid arthritis)
You are currently taking immune-suppressing medications other than methotrexate or acitretin (for example, prednisone or cyclosporine)
You have a serious illness with a short life expectancy (for example, advanced cancer), or you have psoriatic arthritis that is currently not well controlled
You are not able to follow the steps and requirements of the study for any reason (confirm with trial site)
You are currently trying to become pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Jo Lambert, Prof., University Hospital, Ghent

Phone: 093322298

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06398106

Sponsor: University Hospital, Ghent

Phase: Phase 4

Status: Recruiting

Condition: Psoriasis

Trial contact: 093322298

More information: https://clinicaltrials.gov/study/NCT06398106

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older
You have been formally diagnosed with plaque psoriasis by a qualified skin specialist (dermatologist)
You are currently being treated with one of these three medications — secukinumab, ixekizumab, or guselkumab — and have been taking it at the standard dose for at least 6 months
You are willing and able to sign a consent form before the study begins

Who may not be able to join:

You are taking one of these biologic medications mainly for a condition other than plaque psoriasis (for example, if your primary reason for the medication is rheumatoid arthritis)
You are currently taking immune-suppressing medications other than methotrexate or acitretin (for example, prednisone or cyclosporine)
You have a serious illness with a short life expectancy (for example, advanced cancer), or you have psoriatic arthritis that is currently not well controlled
You are not able to follow the steps and requirements of the study for any reason (confirm with trial site)
You are currently trying to become pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

University Hospital, Ghent

Registry

ClinicalTrials.gov

Start date

20 December 2024

Est. completion

1 March 2028

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Non-inferiority of sustained disease control

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov